You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

43 search results for: expert insights

<b>Expert</b> <b>Insights</b>: Importance of Lung Function Assessment in Pediatric Asthma Patients

expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

2 min

Pulmonology

Dr. Michael Blaiss describes the importance of lung function assessment in pediatric asthma management.

expert video

Assessing EoE: Assessing Histologic Features in EoE

6 min

Gastroenterology

Expert gastroenterologist Dr. Ikuo Hirano reviews the histologic features of EoE and provides insights on their assessment.

ADVENT On Air | First-hand Experience: Practical <b>Insights</b> On the Diagnosis and Assessment of Atopic Dermatitis of the Hands and Feet

audio

ADVENT On Air | First-hand Experience: Practical Insights On the Diagnosis and Assessment of Atopic Dermatitis of the Hands and Feet

20 min

Type 2 Inflammation

This podcast episode discusses best practices for the diagnosis of atopic dermatitis of the hands and feet

<b>Expert</b> Interview: Neuroimmune Interactions in PN and CSU

expert video

Expert Interview: Neuroimmune Interactions in PN and CSU

2 min

Dermatology

Dr. Kim describes current understandings of neuroimmune interactions in PN and CSU, including the roles of neurogenic inflammation in each disease.

expert video

Expert Interview: Inflammatory Cell Infiltrate and Type 2 Inflammation in PN and CSU

2 min

Dermatology

Dr. Metz describes the inflammatory cell infiltrate seen in PN and CSU and how inflammatory cells in the skin contribute to a type 2 inflammatory environment.

IRS-ISIAN 2024 | Emerging <b>Expert</b> Definitions of Remission in CRSwNP

expert video

IRS-ISIAN 2024 | Emerging Expert Definitions of Remission in CRSwNP

3 min

Rhinology

Prof. Peter Hellings highlights the EPOS/EUFOREA 2024 definition of remission and calls for an elevation of treatment goals in CRSwNP.

expert video

Expert Interview: The Importance of Explaining Disease Pathogenesis to PN and CSU Patients

2 min

Dermatology

Dr. Elmariah reveals how discussing disease pathogenesis with PN and CSU patients can contribute to a positive patient-physician relationship.

expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

2 min

Pulmonology

Join global expert Professor Ian Pavord as he discusses the heterogeneity of underlying inflammation in patients with COPD.

expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

42 min

Dermatology

In this ADVENT symposium at the 2024 Diversity in Dermatology conference, experts Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on diagnostic considerations for atopic dermatitis and prurigo nodularis and how clinical signs and itch in these diseases are impacted by type 2 inflammation.

expert video

EAACI 2022 | Unmet Needs in the Diagnosis and Management of Chronic Urticaria

10 min

Dermatology

Join Dr. Autumn Burnette as she discusses the unmet needs in the diagnosis and management of chronic urticaria.

expert video

Pathophysiology of Prurigo Nodularis

8 min

Dermatology

Dr. Shawn Kwatra discusses the role of type 2 inflammation in the pathophysiology of prurigo nodularis.

expert video

CSU is Associated With a High Burden and Impact on Quality of Life

2 min

Dermatology

Dr. Casale discusses delays in diagnosing CSU, the impact of severe itch on daily life and mental health, and the challenges in achieving remission.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region